Month: September 2024

Sep 30 2024

Uncategorized

This FDA-approved drug promises a new way to treat schizophrenia

by Clinical Editor

No Comments

Bristol Myers Squibb’s drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than antipsychotic treatments …

Sep 30 2024

Uncategorized

FDA approves of a new schizophrenia drug

by Clinical Editor

No Comments

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.The drug, generically called Cob …

Sep 29 2024

Uncategorized

FDA approves a novel drug for schizophrenia, a potential ‘game changer’

by Clinical Editor

No Comments

The U.S. Food and Drug Administration late Thursday approved a new kind of drug to treat schizophrenia, a breakthrough after 70 years of incremental innovation that appears to avoid side...

Sep 29 2024

Uncategorized

Medical Minute: Man With Schizophrenia Shares His Journey To Help De-Stigmatize Psychosis

by Clinical Editor

No Comments

Millions of Americans are affected by psychosis, a condition that includes schizophrenia, bipolar disorder, and depression.

Sep 28 2024

Uncategorized

FDA Approves Potentially Groundbreaking Schizophrenia Drug

by Clinical Editor

No Comments

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.

Sep 28 2024

Uncategorized

New drug for schizophrenia has experts excited

by Clinical Editor

No Comments

New schizophrenia treatment Cobenfy approved by US regulators, offering hope for millions with fewer side effects.

Sep 27 2024

Uncategorized

This FDA-approved drug promises a new way to treat schizophrenia – USA TODAY

by Clinical Editor

No Comments

This FDA-approved drug promises a new way to treat schizophrenia  USA TODAY

Sep 27 2024

Uncategorized

Bristol Myers wins US FDA approval for new type of schizophrenia drug

by Clinical Editor

No Comments

The U.S. Food and Drug Administration approved Bristol Myers Squibb’s schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades.

Sep 26 2024

Uncategorized

Most People With Schizophrenia Aren’t Getting Treated

by Clinical Editor

No Comments

Bareis’ team found that, besides being diagnosed with schizophrenia, more than half (52%) of these patients also had depression, while 17% had been diagnosed with post-traumatic stress disorder (PTSD) …

Sep 26 2024

Uncategorized

Synapse-restoring pill set for human trials as novel schizophrenia treatment

by Clinical Editor

No Comments

Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic lateral sclerosis (ALS), has now set its sights on using the pill to...